{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:09:22Z","timestamp":1792976962668,"version":"4.5.0"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1038\/s41575-020-00361-w","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T13:04:09Z","timestamp":1602507849000},"page":"117-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Viral hepatitis and pregnancy"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4143-1950","authenticated-orcid":false,"given":"Norah A.","family":"Terrault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9329-8018","authenticated-orcid":false,"given":"Miriam T.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-6494","authenticated-orcid":false,"given":"Ka Wang","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-7020","authenticated-orcid":false,"given":"Gonzague","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"361_CR1","unstructured":"World Health Organization. Global hepatitis report, 2017 (WHO, 2017)."},{"key":"361_CR2","unstructured":"Jacobsen, K. H. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review (WHO, 2008)."},{"key":"361_CR3","doi-asserted-by":"crossref","first-page":"a031716","DOI":"10.1101\/cshperspect.a031716","volume":"8","author":"KH Jacobsen","year":"2018","unstructured":"Jacobsen, K. H. Globalization and the changing epidemiology of hepatitis a virus. Cold Spring Harb. Perspect. Med. 8, a031716 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"361_CR4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5468\/ogs.2013.56.6.368","volume":"56","author":"GJ Cho","year":"2013","unstructured":"Cho, G. J. et al. Hepatitis A virus infection during pregnancy in Korea: hepatitis A infection on pregnant women. Obstet. Gynecol. Sci. 56, 368\u2013374 (2013).","journal-title":"Obstet. Gynecol. Sci."},{"key":"361_CR5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1053\/j.gastro.2006.01.007","volume":"130","author":"E Elinav","year":"2006","unstructured":"Elinav, E. et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 130, 1129\u20131134 (2006).","journal-title":"Gastroenterology"},{"key":"361_CR6","first-page":"963","volume":"61","author":"SA Chaudhry","year":"2015","unstructured":"Chaudhry, S. A. & Koren, G. Hepatitis A infection during pregnancy. Can. Fam. Physician 61, 963\u2013964 (2015).","journal-title":"Can. Fam. Physician"},{"key":"361_CR7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1447-0756.2011.01757.x","volume":"38","author":"Y Simsek","year":"2012","unstructured":"Simsek, Y. et al. Fulminant hepatitis A infection in second trimester of pregnancy requiring living-donor liver transplantation. J. Obstet. Gynaecol. Res. 38, 745\u2013748 (2012).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"361_CR8","doi-asserted-by":"publisher","unstructured":"Casey, L. C. et al. Acute liver failure (ALF) in pregnancy: how much is pregnancy-related? Hepatology https:\/\/doi.org\/10.1002\/hep.31144 (2020).","DOI":"10.1002\/hep.31144"},{"key":"361_CR9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0029-7844(96)00259-1","volume":"88","author":"E Leikin","year":"1996","unstructured":"Leikin, E. et al. Intrauterine transmission of hepatitis A virus. Obstet. Gynecol. 88, 690\u2013691 (1996).","journal-title":"Obstet. Gynecol."},{"key":"361_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2018.04.007","volume":"154","author":"W Jiang","year":"2018","unstructured":"Jiang, W. et al. Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system. Antivir. Res. 154, 51\u201357 (2018).","journal-title":"Antivir. Res."},{"key":"361_CR11","first-page":"1","volume":"55","author":"AE Fiore","year":"2006","unstructured":"Advisory Committee on Immunization Practices, Fiore, A. E., Wasley, A. & Bell, B. P. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 55, 1\u201323 (2006).","journal-title":"MMWR Recomm. Rep."},{"key":"361_CR12","doi-asserted-by":"crossref","first-page":"561.e1","DOI":"10.1016\/j.ajog.2013.12.036","volume":"210","author":"PL Moro","year":"2014","unstructured":"Moro, P. L. et al. Reports to the vaccine adverse event reporting system after hepatitis a and hepatitis AB vaccines in pregnant women. Am. J. Obstet. Gynecol. 210, 561.e1\u2013561.e6 (2014).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"361_CR13","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1016\/j.vaccine.2019.09.043","volume":"37","author":"HC Groom","year":"2019","unstructured":"Groom, H. C. et al. Uptake and safety of hepatitis A vaccination during pregnancy: a vaccine safety datalink study. Vaccine 37, 6648\u20136655 (2019).","journal-title":"Vaccine"},{"key":"361_CR14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41575-020-0296-6","volume":"17","author":"PA Revill","year":"2020","unstructured":"Revill, P. A. et al. The evolution and clinical impact of hepatitis B virus genome diversity. Nat. Rev. Gastroenterol. Hepatol. 17, 618\u2013634 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"361_CR15","doi-asserted-by":"crossref","first-page":"a021410","DOI":"10.1101\/cshperspect.a021410","volume":"5","author":"JH MacLachlan","year":"2015","unstructured":"MacLachlan, J. H. & Cowie, B. C. Hepatitis B virus epidemiology. Cold Spring Harb. Perspect. Med. 5, a021410 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"361_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1098\/rspb.1993.0102","volume":"253","author":"WJ Edmunds","year":"1993","unstructured":"Edmunds, W. J. et al. The influence of age on the development of the hepatitis B carrier state. Proc. R. Soc. Lond. B 253, 197\u2013201 (1993).","journal-title":"Proc. R. Soc. Lond. B"},{"key":"361_CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(81)90832-1","volume":"2","author":"RP Beasley","year":"1981","unstructured":"Beasley, R. P. et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet 2, 388\u2013393 (1981).","journal-title":"Lancet"},{"key":"361_CR18","volume":"6","author":"YC Hu","year":"2018","unstructured":"Hu, Y. C. et al. Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program. PeerJ 6, e4297 (2018).","journal-title":"PeerJ"},{"key":"361_CR19","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1017\/S0950268817001947","volume":"145","author":"SHI Hofstraat","year":"2017","unstructured":"Hofstraat, S. H. I. et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU\/EEA: a systematic review. Epidemiol. Infect. 145, 2873\u20132885 (2017).","journal-title":"Epidemiol. Infect."},{"key":"361_CR20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/infdis\/jiy706","volume":"220","author":"WJ Su","year":"2019","unstructured":"Su, W. J. et al. The impact of universal infant hepatitis B immunization on reducing the hepatitis B carrier rate in pregnant women. J. Infect. Dis. 220, 1118\u20131126 (2019).","journal-title":"J. Infect. Dis."},{"key":"361_CR21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0033354916663183","volume":"131","author":"TY Walker","year":"2016","unstructured":"Walker, T. Y. et al. Characteristics of pregnant women with hepatitis B virus infection in 5 US public health jurisdictions, 2008-2012. Public Health Rep. 131, 685\u2013694 (2016).","journal-title":"Public Health Rep."},{"key":"361_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxj009","volume":"28","author":"CW Shepard","year":"2006","unstructured":"Shepard, C. W. et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 28, 112\u2013125 (2006).","journal-title":"Epidemiol. Rev."},{"key":"361_CR23","unstructured":"US Department of Health and Human Services. Hepatitis B basic information. HHS.gov https:\/\/www.hhs.gov\/hepatitis\/learn-about-viral-hepatitis\/hepatitis-b-basics\/index.html (2019)."},{"key":"361_CR24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","volume":"34","author":"ST Goldstein","year":"2005","unstructured":"Goldstein, S. T. et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int. J. Epidemiol. 34, 1329\u20131339 (2005).","journal-title":"Int. J. Epidemiol."},{"key":"361_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-018-2120-7","volume":"18","author":"JN Torimiro","year":"2018","unstructured":"Torimiro, J. N. et al. Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy. BMC Pregnancy Childbirth 18, 504 (2018).","journal-title":"BMC Pregnancy Childbirth"},{"key":"361_CR26","doi-asserted-by":"crossref","first-page":"e624","DOI":"10.1016\/S2214-109X(17)30142-0","volume":"5","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study. Lancet Glob. Health 5, e624\u2013e632 (2017).","journal-title":"Lancet Glob. Health"},{"key":"361_CR27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.24927","volume":"90","author":"X Ma","year":"2018","unstructured":"Ma, X. et al. Chronic hepatitis B virus infection and preterm labor(birth) in pregnant women\u2013an updated systematic review and meta-analysis. J. Med. Virol. 90, 93\u2013100 (2018).","journal-title":"J. Med. Virol."},{"key":"361_CR28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2005.05.023","volume":"43","author":"KY Tse","year":"2005","unstructured":"Tse, K. Y., Ho, L. F. & Lao, T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J. Hepatol. 43, 771\u2013775 (2005).","journal-title":"J. Hepatol."},{"key":"361_CR29","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jvh.12964","volume":"25","author":"J Tan","year":"2018","unstructured":"Tan, J. et al. Hepatitis B surface antigen positivity during pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis. J. Viral Hepat. 25, 1372\u20131383 (2018).","journal-title":"J. Viral Hepat."},{"key":"361_CR30","volume":"14","author":"Y-T Han","year":"2014","unstructured":"Han, Y.-T. et al. Clinical features and outcome of acute hepatitis B in pregnancy. BMC Infect. Dis. 14, 368 (2014).","journal-title":"BMC Infect. Dis."},{"key":"361_CR31","first-page":"356560","volume":"2013","author":"N Kimmich","year":"2013","unstructured":"Kimmich, N. et al. Liver transplantation during pregnancy for acute liver failure due to HBV infection: a case report. Case Rep. Obstet. Gynecol. 2013, 356560 (2013).","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"361_CR32","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.14309\/ajg.0000000000000221","volume":"114","author":"NH Bzowej","year":"2019","unstructured":"Bzowej, N. H. et al. Total alanine aminotransferase (ALT) flares in pregnant North American women with chronic hepatitis B infection: results from a prospective observational study. Am. J. Gastroenterol. 114, 1283\u20131291 (2019).","journal-title":"Am. J. Gastroenterol."},{"key":"361_CR33","volume":"94","author":"J Liu","year":"2015","unstructured":"Liu, J. et al. Kinetic changes of viremia and viral antigens of hepatitis B virus during and after pregnancy. Medicine 94, e2001 (2015).","journal-title":"Medicine"},{"key":"361_CR34","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/00365540310016547","volume":"35","author":"A Soderstrom","year":"2003","unstructured":"Soderstrom, A., Norkrans, G. & Lindh, M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand. J. Infect. Dis. 35, 814\u2013819 (2003).","journal-title":"Scand. J. Infect. Dis."},{"key":"361_CR35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2893.2007.00894.x","volume":"15","author":"MJ ter Borg","year":"2008","unstructured":"ter Borg, M. J. et al. Exacerbation of chronic hepatitis B infection after delivery. J. Viral Hepat. 15, 37\u201341 (2008).","journal-title":"J. Viral Hepat."},{"key":"361_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890290102","volume":"29","author":"HH Lin","year":"1989","unstructured":"Lin, H. H. et al. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers. J. Med. Virol. 29, 1\u20136 (1989).","journal-title":"J. Med. Virol."},{"key":"361_CR37","volume":"78","author":"SS Joshi","year":"2017","unstructured":"Joshi, S. S. et al. Peripartum cytokine flares in a multiethnic cohort of chronic hepatitis B carriers does not correlate with hepatitis B virus suppression or increased risk of liver disease. Am. J. Reprod. Immunol. 78, e12707 (2017).","journal-title":"Am. J. Reprod. Immunol."},{"key":"361_CR38","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/apt.12726","volume":"39","author":"V Nguyen","year":"2014","unstructured":"Nguyen, V. et al. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Aliment. Pharmacol. Ther. 39, 1225\u20131234 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"361_CR39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/liv.13594","volume":"38","author":"T Kushner","year":"2018","unstructured":"Kushner, T. et al. Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: a regional hospital-based cohort study. Liver Int. 38, 813\u2013820 (2018).","journal-title":"Liver Int."},{"key":"361_CR40","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan, C. Q. et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N. Engl. J. Med. 374, 2324\u20132334 (2016).","journal-title":"N. Engl. J. Med."},{"key":"361_CR41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2014.04.038","volume":"61","author":"AJ Greenup","year":"2014","unstructured":"Greenup, A. J. et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J. Hepatol. 61, 502\u2013507 (2014).","journal-title":"J. Hepatol."},{"key":"361_CR42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1708131","volume":"378","author":"G Jourdain","year":"2018","unstructured":"Jourdain, G. et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N. Engl. J. Med. 378, 911\u2013923 (2018).","journal-title":"N. Engl. J. Med."},{"key":"361_CR43","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67, 1560\u20131599 (2018).","journal-title":"Hepatology"},{"key":"361_CR44","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1136\/gutjnl-2014-308211","volume":"64","author":"M Giles","year":"2015","unstructured":"Giles, M. et al. Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B. Gut 64, 1810\u20131815 (2015).","journal-title":"Gut"},{"key":"361_CR45","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/MCG.0000000000000877","volume":"52","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Baseline hepatitis B virus titer predicts initial postpartum hepatic flare: a multicenter prospective study. J. Clin. Gastroenterol. 52, 902\u2013907 (2017).","journal-title":"J. Clin. Gastroenterol."},{"key":"361_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30586-7","author":"A Funk","year":"2020","unstructured":"Funk, A. et al. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(20)30586-7 (2020).","journal-title":"Lancet Infect Dis."},{"key":"361_CR47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.28302","volume":"63","author":"RS Brown Jr","year":"2016","unstructured":"Brown, R. S. Jr et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology 63, 319\u2013333 (2016).","journal-title":"Hepatology"},{"key":"361_CR48","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.dld.2018.11.003","volume":"51","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Presence of hepatitis B virus markers in umbilical cord blood: exposure to or infection with the virus? Dig. Liver Dis. 51, 864\u2013869 (2019).","journal-title":"Dig. Liver Dis."},{"key":"361_CR49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.14218\/JCTH.2016.00067","volume":"5","author":"MG Mavilia","year":"2017","unstructured":"Mavilia, M. G. & Wu, G. Y. Mechanisms and prevention of vertical transmission in chronic viral hepatitis. J. Clin. Transl. Hepatol. 5, 119\u2013129 (2017).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"361_CR50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7262.2006.00141.x","volume":"8","author":"BA Ali","year":"2006","unstructured":"Ali, B. A. et al. Expression of hepatitis B virus genes in early embryonic cells originated from hamster ova and human spermatozoa transfected with the complete viral genome. Asian J. Androl. 8, 273\u2013279 (2006).","journal-title":"Asian J. Androl."},{"key":"361_CR51","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.fertnstert.2010.12.043","volume":"95","author":"R Nie","year":"2011","unstructured":"Nie, R. et al. Presence of hepatitis B virus in oocytes and embryos: a risk of hepatitis B virus transmission during in vitro fertilization. Fertil. Steril. 95, 1667\u20131671 (2011).","journal-title":"Fertil. Steril."},{"key":"361_CR52","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/humrep\/der103","volume":"26","author":"XL Hu","year":"2011","unstructured":"Hu, X. L. et al. The presence and expression of the hepatitis B virus in human oocytes and embryos. Hum. Reprod. 26, 1860\u20131867 (2011).","journal-title":"Hum. Reprod."},{"key":"361_CR53","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.vaccine.2010.05.008","volume":"28","author":"WHO Publication","year":"2010","unstructured":"WHO Publication. Hepatitis B vaccines: WHO position paper \u2014 recommendations. Vaccine 28, 589\u2013590 (2010).","journal-title":"Vaccine"},{"key":"361_CR54","unstructured":"Centers for Disease Control and Prevention. Perinatal transmission. CDC https:\/\/www.cdc.gov\/hepatitis\/hbv\/perinatalxmtn.htm (2020)."},{"key":"361_CR55","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2772-3","volume":"17","author":"A Amini","year":"2017","unstructured":"Amini, A. et al. Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis. BMC Infect. Dis. 17, 698 (2017).","journal-title":"BMC Infect. Dis."},{"key":"361_CR56","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/aogs.13631","volume":"98","author":"KW Cheung","year":"2019","unstructured":"Cheung, K. W. et al. Optimal timing of hepatitis B virus DNA quantification and clinical predictors for higher viral load during pregnancy. Acta Obstet. Gynecol. Scand. 98, 1301\u20131306 (2019).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"361_CR57","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/hep.28589","volume":"64","author":"WH Wen","year":"2016","unstructured":"Wen, W. H. et al. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection. Hepatology 64, 1451\u20131461 (2016).","journal-title":"Hepatology"},{"key":"361_CR58","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/liv.13139","volume":"36","author":"G Samadi Kochaksaraei","year":"2016","unstructured":"Samadi Kochaksaraei, G. et al. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk. Liver Int. 36, 1604\u20131610 (2016).","journal-title":"Liver Int."},{"key":"361_CR59","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/liv.13736","volume":"38","author":"C Thilakanathan","year":"2018","unstructured":"Thilakanathan, C. et al. Mother-to-child transmission of hepatitis B: examining viral cut-offs, maternal HBsAg serology and infant testing. Liver Int. 38, 1212\u20131219 (2018).","journal-title":"Liver Int."},{"key":"361_CR60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejogrb.2018.11.017","volume":"232","author":"KW Cheung","year":"2019","unstructured":"Cheung, K. W. et al. The effect of rupture of membranes and labour on the risk of hepatitis B vertical transmission: prospective multicentre observational study. Eur. J. Obstet. Gynecol. Reprod. Biol. 232, 97\u2013100 (2019).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"361_CR61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/pd.5452","volume":"39","author":"Z Han","year":"2019","unstructured":"Han, Z. et al. Mother-to-child transmission of hepatitis B virus after amniocentesis: a retrospective matched cohort study. Prenat. Diagn. 39, 431\u2013440 (2019).","journal-title":"Prenat. Diagn."},{"key":"361_CR62","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2013.11.008","volume":"60","author":"W Yi","year":"2014","unstructured":"Yi, W. et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J. Hepatol. 60, 523\u2013529 (2014).","journal-title":"J. Hepatol."},{"key":"361_CR63","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1067\/mob.2001.117968","volume":"185","author":"DZ Xu","year":"2001","unstructured":"Xu, D. Z. et al. Role of placental tissues in the intrauterine transmission of hepatitis B virus. Am. J. Obstet. Gynecol. 185, 981\u2013987 (2001).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"361_CR64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/1471-0528.14050","volume":"124","author":"FL Mackie","year":"2017","unstructured":"Mackie, F. L. et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG 124, 32\u201346 (2017).","journal-title":"BJOG"},{"key":"361_CR65","volume":"17","author":"M Yang","year":"2017","unstructured":"Yang, M. et al. Cesarean section to prevent mother-to-child transmission of hepatitis B virus in China: a meta-analysis. BMC Pregnancy Childbirth 17, 303 (2017).","journal-title":"BMC Pregnancy Childbirth"},{"key":"361_CR66","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/jp.2014.167","volume":"34","author":"JC Dunkelberg","year":"2014","unstructured":"Dunkelberg, J. C. et al. Hepatitis B and C in pregnancy: a review and recommendations for care. J. Perinatol. 34, 882\u2013891 (2014).","journal-title":"J. Perinatol."},{"key":"361_CR67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jmv.1890030310","volume":"3","author":"CE Stevens","year":"1979","unstructured":"Stevens, C. E. et al. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J. Med. Virol. 3, 237\u2013241 (1979).","journal-title":"J. Med. Virol."},{"key":"361_CR68","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","volume":"19","author":"H Zou","year":"2012","unstructured":"Zou, H. et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J. Viral Hepat. 19, e18\u2013e25 (2012).","journal-title":"J. Viral Hepat."},{"key":"361_CR69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2013.02.015","volume":"59","author":"WH Wen","year":"2013","unstructured":"Wen, W. H. et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J. Hepatol. 59, 24\u201330 (2013).","journal-title":"J. Hepatol."},{"key":"361_CR70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cgh.2017.07.013","volume":"16","author":"KW Cheung","year":"2018","unstructured":"Cheung, K. W. et al. Immunoprophylaxis failure of infants born to hepatitis B carrier mothers following routine vaccination. Clin. Gastroenterol. Hepatol. 16, 144\u2013145 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"361_CR71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","volume":"190","author":"E Wiseman","year":"2009","unstructured":"Wiseman, E. et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med. J. Aust. 190, 489\u2013492 (2009).","journal-title":"Med. J. Aust."},{"key":"361_CR72","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/QAI.0000000000001618","volume":"77","author":"V Benhammou","year":"2018","unstructured":"Benhammou, V. et al. HBV or HCV coinfection in HIV-1-infected pregnant women in France: prevalence and pregnancy outcomes. J. Acquir. Immune Defic. Syndr. 77, 439\u2013450 (2018).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"361_CR73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/hiv.12120","volume":"15","author":"V Mave","year":"2014","unstructured":"Mave, V. et al. Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV. HIV. Med. 15, 347\u2013354 (2014).","journal-title":"HIV. Med."},{"key":"361_CR74","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1016\/j.vaccine.2015.06.076","volume":"33","author":"N Chotun","year":"2015","unstructured":"Chotun, N. et al. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. Vaccine 33, 4618\u20134622 (2015).","journal-title":"Vaccine"},{"key":"361_CR75","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/adc.66.8.983","volume":"66","author":"J Vanclaire","year":"1991","unstructured":"Vanclaire, J., Cornu, C. & Sokal, E. M. Fulminant hepatitis B in an infant born to a hepatitis Be antibody positive, DNA negative carrier. Arch. Dis. Child. 66, 983\u2013985 (1991).","journal-title":"Arch. Dis. Child."},{"key":"361_CR76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1542\/peds.72.2.176","volume":"72","author":"D Delaplane","year":"1983","unstructured":"Delaplane, D. et al. Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics 72, 176\u2013180 (1983).","journal-title":"Pediatrics"},{"key":"361_CR77","first-page":"141","volume":"21","author":"M Sacher","year":"1986","unstructured":"Sacher, M., Unger, F. D. & Eder, G. Vertical hepatitis B transmission by anti-HBe positive hepatitis B carrier mothers. Padiatr. Padol. 21, 141\u2013146 (1986).","journal-title":"Padiatr. Padol."},{"key":"361_CR78","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jmv.1890470408","volume":"47","author":"A Bahn","year":"1995","unstructured":"Bahn, A. et al. Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants. J. Med. Virol. 47, 336\u2013341 (1995).","journal-title":"J. Med. Virol."},{"key":"361_CR79","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF01954085","volume":"152","author":"E Schaefer","year":"1993","unstructured":"Schaefer, E., Koeppen, H. & Wirth, S. Low level virus replication in infants with vertically transmitted fulminant hepatitis and their anti-HBe positive mothers. Eur. J. Pediatr. 152, 581\u2013584 (1993).","journal-title":"Eur. J. Pediatr."},{"key":"361_CR80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.20006","volume":"39","author":"HL Chen","year":"2004","unstructured":"Chen, H. L. et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 39, 58\u201363 (2004).","journal-title":"Hepatology"},{"key":"361_CR81","doi-asserted-by":"crossref","DOI":"10.1186\/s40249-019-0526-8","volume":"8","author":"JJ Bigna","year":"2019","unstructured":"Bigna, J. J. et al. Gender development and hepatitis B and C infections among pregnant women in Africa: a systematic review and meta-analysis. Infect. Dis. Poverty 8, 16 (2019).","journal-title":"Infect. Dis. Poverty"},{"key":"361_CR82","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Prevalence of chronic hepatitis B and status of HBV care among rural women who planned to conceive in China. Sci. Rep. 7, 12090 (2017).","journal-title":"Sci. Rep."},{"key":"361_CR83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcv.2018.10.007","volume":"109","author":"O Segeral","year":"2018","unstructured":"Segeral, O. et al. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study. J. Clin. Virol. 109, 29\u201334 (2018).","journal-title":"J. Clin. Virol."},{"key":"361_CR84","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2016.08.009","volume":"66","author":"M Cornberg","year":"2017","unstructured":"Cornberg, M. et al. The role of quantitative hepatitis B surface antigen revisited. J. Hepatol. 66, 398\u2013411 (2017).","journal-title":"J. Hepatol."},{"key":"361_CR85","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol. 67, 370\u2013398 (2017).","journal-title":"J. Hepatol."},{"key":"361_CR86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijid.2015.11.002","volume":"41","author":"M Fujiko","year":"2015","unstructured":"Fujiko, M. et al. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction? Int. J. Infect. Dis. 41, 83\u201389 (2015).","journal-title":"Int. J. Infect. Dis."},{"key":"361_CR87","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1016\/j.vaccine.2012.06.036","volume":"30","author":"KX Sun","year":"2012","unstructured":"Sun, K. X. et al. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. Vaccine 30, 5335\u20135340 (2012).","journal-title":"Vaccine"},{"key":"361_CR88","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcv.2019.01.002","volume":"111","author":"NH Patel","year":"2019","unstructured":"Patel, N. H. et al. Analysis of serum hepatitis B virus RNA levels in a multiethnic cohort of pregnant chronic hepatitis B carriers. J. Clin. Virol. 111, 42\u201347 (2019).","journal-title":"J. Clin. Virol."},{"key":"361_CR89","first-page":"1442","volume":"70","author":"Y Shimakawa","year":"2019","unstructured":"Shimakawa, Y. et al. Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa. Clin. Infect. Dis. 70, 1442\u20131452 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"361_CR90","volume":"95","author":"C Wang","year":"2016","unstructured":"Wang, C. et al. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure. Medicine 95, e4390 (2016).","journal-title":"Medicine"},{"key":"361_CR91","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1016\/j.vaccine.2014.04.045","volume":"32","author":"W Kang","year":"2014","unstructured":"Kang, W. et al. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province, China. Vaccine 32, 3362\u20133366 (2014).","journal-title":"Vaccine"},{"key":"361_CR92","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1016\/j.vaccine.2011.06.065","volume":"29","author":"D Isaacs","year":"2011","unstructured":"Isaacs, D. et al. Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation. Vaccine 29, 6159\u20136162 (2011).","journal-title":"Vaccine"},{"key":"361_CR93","first-page":"CD008545","volume":"2","author":"AC Eke","year":"2017","unstructured":"Eke, A. C. et al. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Cochrane Database Syst. Rev. 2, CD008545 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"361_CR94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.vaccine.2017.11.027","volume":"36","author":"L Childs","year":"2018","unstructured":"Childs, L., Roesel, S. & Tohme, R. A. Status and progress of hepatitis B control through vaccination in the South-East Asia region, 1992-2015. Vaccine 36, 6\u201314 (2018).","journal-title":"Vaccine"},{"key":"361_CR95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.11604\/pamj.supp.2017.27.3.11981","volume":"27","author":"L Breakwell","year":"2017","unstructured":"Breakwell, L. et al. The status of hepatitis B control in the African region. Pan Afr. Med. J. 27, 17 (2017).","journal-title":"Pan Afr. Med. J."},{"key":"361_CR96","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.vaccine.2016.03.060","volume":"34","author":"E Wiesen","year":"2016","unstructured":"Wiesen, E., Diorditsa, S. & Li, X. Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990\u20132014. Vaccine 34, 2855\u20132862 (2016).","journal-title":"Vaccine"},{"key":"361_CR97","doi-asserted-by":"crossref","first-page":"J36","DOI":"10.1016\/j.vaccine.2012.11.061","volume":"31","author":"F Cui","year":"2013","unstructured":"Cui, F. et al. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation. Vaccine 31, J36\u2013J42 (2013).","journal-title":"Vaccine"},{"key":"361_CR98","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1016\/j.vaccine.2016.09.056","volume":"34","author":"A Xeuatvongsa","year":"2016","unstructured":"Xeuatvongsa, A. et al. Improving hepatitis B birth dose in rural Lao People\u2019s Democratic Republic through the use of mobile phones to facilitate communication. Vaccine 34, 5777\u20135784 (2016).","journal-title":"Vaccine"},{"key":"361_CR99","unstructured":"World Health Organization. A systematic review of monovalent hepatitis B vaccine thermostability (WHO, 2016)."},{"key":"361_CR100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S2468-1253(16)30031-0","volume":"1","author":"S Wait","year":"2016","unstructured":"Wait, S. et al. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments. Lancet Gastroenterol. Hepatol. 1, 248\u2013255 (2016).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"361_CR101","unstructured":"Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral pregnancy registry interim report for 1 January 1989 through 31 January 2020 (Registry Coordinating Center, 2020)."},{"key":"361_CR102","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jvh.12212","volume":"21","author":"A Ayres","year":"2014","unstructured":"Ayres, A. et al. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations. J. Viral Hepat. 21, 809\u2013817 (2014).","journal-title":"J. Viral Hepat."},{"key":"361_CR103","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3748\/wjg.v21.i8.2504","volume":"21","author":"YH Hu","year":"2015","unstructured":"Hu, Y. H. et al. Tenofovir rescue therapy in pregnant females with chronic hepatitis B. World J. Gastroenterol. 21, 2504\u20132509 (2015).","journal-title":"World J. Gastroenterol."},{"key":"361_CR104","unstructured":"World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection (WHO, 2015)."},{"key":"361_CR105","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1128\/JCM.42.11.5199-5204.2004","volume":"42","author":"V Shyamala","year":"2004","unstructured":"Shyamala, V. et al. Assessment of the target-capture PCR hepatitis B virus (HBV) DNA quantitative assay and comparison with commercial HBV DNA quantitative assays. J. Clin. Microbiol. 42, 5199\u20135204 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"361_CR106","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","volume":"55","author":"GR Han","year":"2011","unstructured":"Han, G. R. et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J. Hepatol. 55, 1215\u20131221 (2011).","journal-title":"J. Hepatol."},{"key":"361_CR107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin, S. K. et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol. Int. 10, 1\u201398 (2016).","journal-title":"Hepatol. Int."},{"key":"361_CR108","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpediatrics.2011.72","volume":"165","author":"Z Shi","year":"2011","unstructured":"Shi, Z. et al. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch. Pediatr. Adolesc. Med. 165, 837\u2013846 (2011).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"361_CR109","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-502","volume":"11","author":"Y Zheng","year":"2011","unstructured":"Zheng, Y. et al. Should chronic hepatitis B mothers breastfeed? A meta analysis. BMC Public Health 11, 502 (2011).","journal-title":"BMC Public Health"},{"key":"361_CR110","unstructured":"World Health Organization. Hepatitis B and breastfeeding (WHO, 1996)."},{"key":"361_CR111","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2019.07.023","volume":"87","author":"X Hu","year":"2019","unstructured":"Hu, X., Wang, L. & Xu, F. Guides concerning tenofovir exposure via breastfeeding: a comparison of drug dosages by developmental stage. Int. J. Infect. Dis. 87, 8\u201312 (2019).","journal-title":"Int. J. Infect. Dis."},{"key":"361_CR112","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.00514-10","volume":"55","author":"S Benaboud","year":"2011","unstructured":"Benaboud, S. et al. Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d\u2019Ivoire, in the ANRS 12109 TEmAA Study, Step 2. Antimicrob. Agents Chemother. 55, 1315\u20131317 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"361_CR113","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/COH.0000000000000248","volume":"11","author":"PM Grant","year":"2016","unstructured":"Grant, P. M. & Cotter, A. G. Tenofovir and bone health. Curr. Opin. HIV AIDS 11, 326\u2013332 (2016).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"361_CR114","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.15585\/mmwr.mm6439a6","volume":"64","author":"S Schillie","year":"2015","unstructured":"Schillie, S. et al. Update: Shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers. Morb. Mortal. Wkly. Rep. 64, 1118\u20131120 (2015).","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"361_CR115","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S2468-1253(19)30042-1","volume":"4","author":"G Indolfi","year":"2019","unstructured":"Indolfi, G. et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol. Hepatol. 4, 466\u2013476 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"361_CR116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5365\/wpsar.2017.8.3.005","volume":"8","author":"J Woodring","year":"2017","unstructured":"Woodring, J. et al. Integrating HIV, hepatitis B and syphilis screening and treatment through the Maternal, Newborn and Child Health platform to reach global elimination targets. West. Pac. Surveill. Response J. 8, 1\u20135 (2017).","journal-title":"West. Pac. Surveill. Response J."},{"key":"361_CR117","unstructured":"Gavi. Gavi Alliance Programme and Policy Committee meeting 23\u201324 October 2019 (Gavi, 2019)."},{"key":"361_CR118","unstructured":"World Health Organization. Guidelines on hepatitis B and C testing (WHO, 2016)."},{"key":"361_CR119","doi-asserted-by":"crossref","first-page":"100264","DOI":"10.1016\/j.eclinm.2020.100264","volume":"19","author":"W Jing","year":"2020","unstructured":"Jing, W. et al. Cost-effectiveness of couple-based immunization strategy to prevent mother-to-child transmission of hepatitis B virus in China: a decision-analytic Markov model. EClinicalMedicine 19, 100264 (2020).","journal-title":"EClinicalMedicine"},{"key":"361_CR120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jvh.12524","volume":"23","author":"R Rajbhandari","year":"2016","unstructured":"Rajbhandari, R. et al. Discontinuity of care for mothers with chronic hepatitis B diagnosed during pregnancy. J. Viral Hepat. 23, 561\u2013568 (2016).","journal-title":"J. Viral Hepat."},{"key":"361_CR121","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.puhe.2018.12.008","volume":"168","author":"KW Cheung","year":"2019","unstructured":"Cheung, K. W. et al. Pattern and predictors of medical care received by hepatitis B carriers during pregnancy and after delivery. Public Health 168, 36\u201342 (2019).","journal-title":"Public Health"},{"key":"361_CR122","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.30342","volume":"69","author":"C Davis","year":"2019","unstructured":"Davis, C. et al. Highly diverse hepatitis C strains detected in sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments. Hepatology 69, 1426\u20131441 (2019).","journal-title":"Hepatology"},{"key":"361_CR123","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cld.2006.08.003","volume":"10","author":"SR Bialek","year":"2006","unstructured":"Bialek, S. R. & Terrault, N. A. The changing epidemiology and natural history of hepatitis C virus infection. Clin. Liver Dis. 10, 697\u2013715 (2006).","journal-title":"Clin. Liver Dis."},{"key":"361_CR124","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/14787210.2019.1588112","volume":"17","author":"L Wei","year":"2019","unstructured":"Wei, L. & Huang, Y. H. Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents. Expert Rev. Anti Infect. Ther. 17, 311\u2013325 (2019).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"361_CR125","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","volume":"22","author":"A Petruzziello","year":"2016","unstructured":"Petruzziello, A. et al. Global epidemiology of hepatitis\u00a0C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J. Gastroenterol. 22, 7824\u20137840 (2016).","journal-title":"World J. Gastroenterol."},{"key":"361_CR126","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/M17-0927","volume":"166","author":"A DeMaria Jr","year":"2017","unstructured":"DeMaria, A. Jr Hearing from the silent epidemic. Ann. Intern. Med. 166, 846\u2013847 (2017).","journal-title":"Ann. Intern. Med."},{"key":"361_CR127","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower, E. et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 61, S45\u2013S57 (2014).","journal-title":"J. Hepatol."},{"key":"361_CR128","first-page":"537","volume":"60","author":"S Onofrey","year":"2011","unstructured":"Onofrey, S. et al. Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002-2009. Morb. Mortal. Wkly. Rep. 60, 537\u2013541 (2011).","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"361_CR129","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/M16-2350","volume":"166","author":"KN Ly","year":"2017","unstructured":"Ly, K. N. et al. Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014. Ann. Intern. Med. 166, 775\u2013782 (2017).","journal-title":"Ann. Intern. Med."},{"key":"361_CR130","unstructured":"American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C (AASLD\/IDSA, 2020)."},{"key":"361_CR131","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/cid\/ciz063","volume":"69","author":"A Chaillon","year":"2019","unstructured":"Chaillon, A. et al. Cost-effectiveness of universal hepatitis C virus screening of pregnant women in the United States. Clin. Infect. Dis. 69, 1888\u20131895 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"361_CR132","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2020.1123","volume":"323","author":"US Preventive Services Task Force","year":"2020","unstructured":"US Preventive Services Task Force et al. Screening for hepatitis C virus infection in adolescents and adults: US preventive services task force recommendation statement. JAMA 323, 970\u2013975 (2020).","journal-title":"JAMA"},{"key":"361_CR133","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/NPM-15915024","volume":"8","author":"W Waruingi","year":"2015","unstructured":"Waruingi, W. et al. Hepatitis C virus universal screening versus risk based selective screening during pregnancy. J. Neonatal Perinat. Med. 8, 371\u2013378 (2015).","journal-title":"J. Neonatal Perinat. Med."},{"key":"361_CR134","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jinf.2015.01.009","volume":"70","author":"SS El-Kamary","year":"2015","unstructured":"El-Kamary, S. S. et al. Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt. J. Infect. 70, 512\u2013519 (2015).","journal-title":"J. Infect."},{"key":"361_CR135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/14767058.2010.531318","volume":"24","author":"R Chibber","year":"2011","unstructured":"Chibber, R., El-Saleh, E. & El Harmi, J. Female circumcision: obstetrical and psychological sequelae continues unabated in the 21st century. J. Matern. Fetal Neonatal Med. 24, 833\u2013836 (2011).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"361_CR136","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","volume":"217","author":"BL Hughes","year":"2017","unstructured":"Society for Maternal-Fetal Medicine, Hughes, B. L., Page, C. M. & Kuller, J. A. Hepatitis C in pregnancy: screening, treatment, and management. Am. J. Obstet. Gynecol. 217, B2\u2013B12 (2017).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"361_CR137","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/liv.14352","volume":"40","author":"M Kaberg","year":"2020","unstructured":"Kaberg, M. & Weiland, O. Hepatitis C elimination - macro-elimination. Liver Int. 40, 61\u201366 (2020).","journal-title":"Liver Int."},{"key":"361_CR138","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jfma.2020.04.002","volume":"119","author":"ML Yu","year":"2020","unstructured":"Yu, M. L. et al. 2020 Taiwan consensus statement on the management of hepatitis C: part (II) special populations. J. Formos. Med. Assoc. 119, 1135\u20131157 (2020).","journal-title":"J. Formos. Med. Assoc."},{"key":"361_CR139","first-page":"6230","volume":"8","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. Effect of hepatitis C virus infection on the outcomes of in vitro fertilization. Int. J. Clin. Exp. Med. 8, 6230\u20136235 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"361_CR140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1753495X17708093","volume":"10","author":"JJ Post","year":"2017","unstructured":"Post, J. J. Update on hepatitis C and implications for pregnancy. Obstet. Med. 10, 157\u2013160 (2017).","journal-title":"Obstet. Med."},{"key":"361_CR141","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10815-017-0892-8","volume":"34","author":"C Shaw-Jackson","year":"2017","unstructured":"Shaw-Jackson, C. et al. In vitro fertilization for women infected by hepatitis C virus: a matched case-control study and a systematic literature review. J. Assist. Reprod. Genet. 34, 587\u2013597 (2017).","journal-title":"J. Assist. Reprod. Genet."},{"key":"361_CR142","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1701-2163(15)30480-1","volume":"36","author":"D Money","year":"2014","unstructured":"Money, D. et al. Obstetrical and neonatal outcomes among women infected with hepatitis C and their infants. J. Obstet. Gynaecol. Can. 36, 785\u2013794 (2014).","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"361_CR143","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/jvh.12430","volume":"22","author":"QT Huang","year":"2015","unstructured":"Huang, Q. T. et al. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies. J. Viral Hepat. 22, 1033\u20131042 (2015).","journal-title":"J. Viral Hepat."},{"key":"361_CR144","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00404-017-4550-2","volume":"296","author":"M Rezk","year":"2017","unstructured":"Rezk, M. & Omar, Z. Deleterious impact of maternal hepatitis-C viral infection on maternal and fetal outcome: a 5-year prospective study. Arch. Gynecol. Obstet. 296, 1097\u20131102 (2017).","journal-title":"Arch. Gynecol. Obstet."},{"key":"361_CR145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MEG.0000000000000293","volume":"27","author":"T Belay","year":"2015","unstructured":"Belay, T. et al. Intrahepatic cholestasis of pregnancy with concomitant hepatitis C virus infection, Joan C. Edwards SOM, Marshall University. Eur. J. Gastroenterol. Hepatol. 27, 372\u2013374 (2015).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"361_CR146","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinre.2016.07.004","volume":"41","author":"K Wijarnpreecha","year":"2017","unstructured":"Wijarnpreecha, K. et al. Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clin. Res. Hepatol. Gastroenterol. 41, 39\u201345 (2017).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"361_CR147","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep4.1282","volume":"3","author":"T Kushner","year":"2019","unstructured":"Kushner, T. & Terrault, N. A. Hepatitis C in pregnancy: a unique opportunity to improve the hepatitis C cascade of care. Hepatol. Commun. 3, 20\u201328 (2019).","journal-title":"Hepatol. Commun."},{"key":"361_CR148","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510310328","volume":"31","author":"D Conte","year":"2000","unstructured":"Conte, D. et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31, 751\u2013755 (2000).","journal-title":"Hepatology"},{"key":"361_CR149","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","volume":"59","author":"L Benova","year":"2014","unstructured":"Benova, L. et al. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin. Infect. Dis. 59, 765\u2013773 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"361_CR150","doi-asserted-by":"crossref","first-page":"F156","DOI":"10.1136\/adc.2004.059436","volume":"90","author":"J Mok","year":"2005","unstructured":"Mok, J. et al. When does mother to child transmission of hepatitis C virus occur? Arch. Dis. Child. Fetal Neonatal Ed. 90, F156\u2013F160 (2005).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"361_CR151","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-158-2-201301150-00575","volume":"158","author":"EB Cottrell","year":"2013","unstructured":"Cottrell, E. B. et al. Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 158, 109\u2013113 (2013).","journal-title":"Ann. Intern. Med."},{"key":"361_CR152","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/apt.15476","volume":"50","author":"JJM Freriksen","year":"2019","unstructured":"Freriksen, J. J. M. et al. Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation \u2013 implications for maternal dosing, foetal exposure, and safety for mother and child. Aliment. Pharmacol. Ther. 50, 738\u2013750 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"361_CR153","doi-asserted-by":"crossref","unstructured":"Chappell C. A. et al. A phase 1 study of ledipasvir\/sofosbuvir in pregnant women with hepatitis C virus [abstract 87]. Presented at the Conference on Retroviruses and Opportunistic Infections (2019).","DOI":"10.2139\/ssrn.3576909"},{"key":"361_CR154","volume":"70","author":"M El-Sayed","year":"2019","unstructured":"El-Sayed, M. et al. THU-137-DAA therapy in women of child bearing age: accidental conception during therapy and pregnancy outcome [abstract]. J. Hepatol. 70, e221 (2019).","journal-title":"J. Hepatol."},{"key":"361_CR155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0040-1708812","volume":"40","author":"MH El-Sayed","year":"2020","unstructured":"El-Sayed, M. H.& Indolfi, G. Hepatitis C virus treatment in children: a challenge for hepatitis C virus elimination. Semin. Liver Dis. 40, 213\u2013224 (2020).","journal-title":"Semin. Liver Dis."},{"key":"361_CR156","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(19)30046-9","volume":"4","author":"G Indolfi","year":"2019","unstructured":"Indolfi, G. et al. Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol. Hepatol. 4, 477\u2013487 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"361_CR157","doi-asserted-by":"crossref","first-page":"010308","DOI":"10.7189\/jogh.10.010308","volume":"10","author":"EH Dahl","year":"2020","unstructured":"Dahl, E. H. et al. Leaving no one behind: towards equitable global elimination of hepatitis C. J. Glob. Health 10, 010308 (2020).","journal-title":"J. Glob. Health"},{"key":"361_CR158","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep4.1264","volume":"2","author":"T Kushner","year":"2018","unstructured":"Kushner, T. et al. Evaluating women\u2019s preferences for hepatitis C treatment during pregnancy. Hepatol. Commun. 2, 1306\u20131310 (2018).","journal-title":"Hepatol. Commun."},{"key":"361_CR159","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1701-2163(15)30546-6","volume":"36","author":"A Gagnon","year":"2014","unstructured":"Gagnon, A. et al. Prenatal invasive procedures in women with hepatitis B, hepatitis C, and\/or human immunodeficiency virus infections. J. Obstet. Gynaecol. Can. 36, 648\u2013653 (2014).","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"361_CR160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2015.09.009","volume":"194","author":"A Garcia-Tejedor","year":"2015","unstructured":"Garcia-Tejedor, A. et al. Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers. Eur. J. Obstet. Gynecol. Reprod. Biol. 194, 173\u2013177 (2015).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"361_CR161","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1086\/497701","volume":"192","author":"EE Mast","year":"2005","unstructured":"Mast, E. E. et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J. Infect. Dis. 192, 1880\u20131889 (2005).","journal-title":"J. Infect. Dis."},{"key":"361_CR162","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/313473","volume":"29","author":"S Polywka","year":"1999","unstructured":"Polywka, S. et al. Low risk of vertical transmission of hepatitis C virus by breast milk. Clin. Infect. Dis. 29, 1327\u20131329 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"361_CR163","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(95)90044-6","volume":"345","author":"R Zimmermann","year":"1995","unstructured":"Zimmermann, R. et al. Hepatitis C virus in breast milk. Lancet 345, 928 (1995).","journal-title":"Lancet"},{"key":"361_CR164","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1471-0528.2001.00088.x","volume":"108","author":"European Paediatric Hepatitis C Virus Network","year":"2001","unstructured":"European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. BJOG 108, 371\u2013377 (2001).","journal-title":"BJOG"},{"key":"361_CR165","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/infdis\/jit519","volume":"208","author":"S Pfaender","year":"2013","unstructured":"Pfaender, S. et al. Inactivation of hepatitis C virus infectivity by human breast milk. J. Infect. Dis. 208, 1943\u20131952 (2013).","journal-title":"J. Infect. Dis."},{"key":"361_CR166","first-page":"543","volume":"79","author":"P Hillemanns","year":"2000","unstructured":"Hillemanns, P. et al. Obstetric risks and vertical transmission of hepatitis C virus infection in pregnancy. Acta Obstet. Gynecol. Scand. 79, 543\u2013547 (2000).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"361_CR167","doi-asserted-by":"crossref","first-page":"ofw021","DOI":"10.1093\/ofid\/ofw021","volume":"3","author":"A Bal","year":"2016","unstructured":"Bal, A. & Petrova, A. Single clinical practice\u2019s report of testing initiation, antibody clearance, and transmission of hepatitis C virus (HCV) in infants of chronically HCV-infected mothers. Open Forum Infect. Dis. 3, ofw021 (2016).","journal-title":"Open Forum Infect. Dis."},{"key":"361_CR168","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmv.20540","volume":"78","author":"S Polywka","year":"2006","unstructured":"Polywka, S. et al. Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J. Med. Virol. 78, 305\u2013310 (2006).","journal-title":"J. Med. Virol."},{"key":"361_CR169","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/MPG.0b013e318258328d","volume":"54","author":"CL Mack","year":"2012","unstructured":"Mack, C. L. et al. NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents. J. Pediatric Gastroenterol. Nutr. 54, 838\u2013855 (2012).","journal-title":"J. Pediatric Gastroenterol. Nutr."},{"key":"361_CR170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/medethics-2019-105692","volume":"46","author":"MS Gross","year":"2020","unstructured":"Gross, M. S., Ruth, A. R. & Rasmussen, S. A. Respect women, promote health and reduce stigma: ethical arguments for universal hepatitis C screening in pregnancy. J. Med. Ethics 46, 674\u2013677 (2020).","journal-title":"J. Med. Ethics"},{"key":"361_CR171","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jama.2019.9365","volume":"322","author":"US Preventive Services Task Force","year":"2019","unstructured":"US Preventive Services Task Force. Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement. JAMA 322, 349\u2013354 (2019).","journal-title":"JAMA"},{"key":"361_CR172","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3273","volume":"141","author":"CA Chappell","year":"2018","unstructured":"Chappell, C. A. et al. Hepatitis C virus screening among children exposed during pregnancy. Pediatrics 141, e20173273 (2018).","journal-title":"Pediatrics"},{"key":"361_CR173","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/cid\/ciw026","volume":"62","author":"DE Kuncio","year":"2016","unstructured":"Kuncio, D. E. et al. Failure to test and identify perinatally infected children born to hepatitis C virus-infected women. Clin. Infect. Dis. 62, 980\u2013985 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"361_CR174","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3851\/IMP2598","volume":"18","author":"MV Alvarado-Mora","year":"2013","unstructured":"Alvarado-Mora, M. V. et al. An update on HDV: virology, pathogenesis and treatment. Antivir. Ther. 18, 541\u2013548 (2013).","journal-title":"Antivir. Ther."},{"key":"361_CR175","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","volume":"73","author":"AJ Stockdale","year":"2020","unstructured":"Stockdale, A. J. et al. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J. Hepatol. 73, 523\u2013532 (2020).","journal-title":"J. Hepatol."},{"key":"361_CR176","first-page":"381","volume":"66","author":"HY Chen","year":"2018","unstructured":"Chen, H. Y. et al. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut 66, 381\u2013382 (2018).","journal-title":"Gut"},{"key":"361_CR177","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jmv.23336","volume":"84","author":"W Mansour","year":"2012","unstructured":"Mansour, W. et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J. Med. Virol. 84, 1186\u20131198 (2012).","journal-title":"J. Med. Virol."},{"key":"361_CR178","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/vim.2019.0048","volume":"32","author":"M Aftab","year":"2019","unstructured":"Aftab, M. et al. Characterization of hepatitis delta virus among pregnant women of Pakistan. Viral Immunol. 32, 335\u2013340 (2019).","journal-title":"Viral Immunol."},{"key":"361_CR179","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/hep.28957","volume":"66","author":"X Chen","year":"2017","unstructured":"Chen, X. et al. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians. Hepatology 66, 1739\u20131749 (2017).","journal-title":"Hepatology"},{"key":"361_CR180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","volume":"378","author":"SA Hughes","year":"2011","unstructured":"Hughes, S. A., Wedemeyer, H. & Harrison, P. M. Hepatitis delta virus. Lancet 378, 73\u201385 (2011).","journal-title":"Lancet"},{"key":"361_CR181","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep4.1255","volume":"2","author":"H Hagstrom","year":"2018","unstructured":"Hagstrom, H. et al. Outcomes of pregnancy in mothers with cirrhosis: a national population-based cohort study of 1.3 million pregnancies. Hepatol. Commun. 2, 1299\u20131305 (2018).","journal-title":"Hepatol. Commun."},{"key":"361_CR182","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/liv.13556","volume":"38","author":"PO Sellier","year":"2018","unstructured":"Sellier, P. O. et al. Hepatitis B virus-hepatitis D virus mother-to-child co-transmission: a retrospective study in a developed country. Liver Int. 38, 611\u2013618 (2018).","journal-title":"Liver Int."},{"key":"361_CR183","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/liv.12078","volume":"33","author":"G Dusheiko","year":"2013","unstructured":"Dusheiko, G. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues. Liver Int. 33, 137\u2013150 (2013).","journal-title":"Liver Int."},{"key":"361_CR184","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrgastro.2012.187","volume":"10","author":"R Aggarwal","year":"2013","unstructured":"Aggarwal, R. Diagnosis of hepatitis E. Nat. Rev. Gastroenterol. Hepatol. 10, 24\u201333 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"361_CR185","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3201\/eid1211.060332","volume":"12","author":"RC Li","year":"2006","unstructured":"Li, R. C. et al. Seroprevalence of hepatitis E virus infection, rural southern People\u2019s Republic of China. Emerg. Infect. Dis. 12, 1682\u20131688 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"361_CR186","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/v8090253","volume":"8","author":"MS Khuroo","year":"2016","unstructured":"Khuroo, M. S., Khuroo, M. S. & Khuroo, N. S. Transmission of hepatitis E virus in developing countries. Viruses 8, 253 (2016).","journal-title":"Viruses"},{"key":"361_CR187","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2016.02.045","volume":"65","author":"Y Debing","year":"2016","unstructured":"Debing, Y. et al. Update on hepatitis E virology: implications for clinical practice. J. Hepatol. 65, 200\u2013212 (2016).","journal-title":"J. Hepatol."},{"key":"361_CR188","volume":"19","author":"M Dagnew","year":"2019","unstructured":"Dagnew, M. et al. Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis. BMC Infect. Dis. 19, 519 (2019).","journal-title":"BMC Infect. Dis."},{"key":"361_CR189","first-page":"298","volume":"113","author":"S Bisayher","year":"2019","unstructured":"Bisayher, S. et al. Seroprevalence and risk factors of hepatitis E among women of childbearing age in the Xieng Khouang province (Lao People\u2019s Democratic Republic), a cross-sectional survey. J. Viral Hepat. 113, 298\u2013304 (2019).","journal-title":"J. Viral Hepat."},{"key":"361_CR190","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/liv.14468","volume":"40","author":"P Li","year":"2020","unstructured":"Li, P. et al. The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis. Liver Int. 40, 1516\u20131528 (2020).","journal-title":"Liver Int."},{"key":"361_CR191","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0033-1338112","volume":"33","author":"R Aggarwal","year":"2013","unstructured":"Aggarwal, R. Hepatitis E: clinical presentation in disease-endemic areas and diagnosis. Semin. Liver Dis. 33, 30\u201340. (2013).","journal-title":"Semin. Liver Dis."},{"key":"361_CR192","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/jvh.13129","volume":"26,","author":"A Berglov","year":"2019","unstructured":"Berglov, A., Hallager, S. & Weis, N. Hepatitis E during pregnancy: maternal and foetal case-fatality rates and adverse outcomes\u2013a systematic review. J. Viral Hepat. 26, 1240\u20131248 (2019).","journal-title":"J. Viral Hepat."},{"key":"361_CR193","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2893.2003.00398.x","volume":"10","author":"MS Khuroo","year":"2003","unstructured":"Khuroo, M. S. & Kamili, S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J. Viral Hepat. 10, 61\u201369 (2003).","journal-title":"J. Viral Hepat."},{"issue":"Suppl. 3","key":"361_CR194","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02779283","volume":"26","author":"H Zhuang","year":"1991","unstructured":"Zhuang, H., Cao, X. Y., Liu, C. B. & Wang, G. M. Epidemiology of hepatitis E in China. Gastroenterol. Jpn. 26 (Suppl. 3), 135\u2013138 (1991).","journal-title":"Gastroenterol. Jpn."},{"key":"361_CR195","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1080\/14767058.2019.1582630","volume":"33","author":"M Li","year":"2020","unstructured":"Li, M. et al. Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China. J. Matern. Fetal Neonatal. Med. 33, 3647\u20133651 (2020).","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"361_CR196","first-page":"117","volume":"2","author":"M El Sayed Zaki","year":"2014","unstructured":"El Sayed Zaki, M., El Razek, M. M. A. & El Razek, H. M. A. Maternal-fetal hepatitis E transmission: is it underestimated? J. Clin. Transl. Hepatol. 2, 117\u2013123 (2014).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"361_CR197","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/CMR.00057-13","volume":"27","author":"N Kamar","year":"2014","unstructured":"Kamar, N. et al. Hepatitis E virus infection. Clin. Microbiol. Rev. 27, 116\u2013138 (2014).","journal-title":"Clin. Microbiol. Rev."},{"key":"361_CR198","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07200-2","volume":"9","author":"J Gouilly","year":"2018","unstructured":"Gouilly, J. et al. Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface. Nat. Commun. 9, 4748 (2018).","journal-title":"Nat. Commun."},{"key":"361_CR199","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep4.1138","volume":"2","author":"L Knegendorf","year":"2018","unstructured":"Knegendorf, L. et al. Hepatitis E virus replication and interferon responses in human placental cells. Hepatol. Commun. 2, 173\u2013187 (2018).","journal-title":"Hepatol. Commun."},{"key":"361_CR200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0973-6247.83238","volume":"5","author":"YZ Gad","year":"2011","unstructured":"Gad, Y. Z. et al. Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt. Asian J. Transfus. Sci. 5, 136\u2013139 (2011).","journal-title":"Asian J. Transfus. Sci."},{"key":"361_CR201","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/jvh.12865","volume":"25","author":"C Yang","year":"2018","unstructured":"Yang, C. et al. Increased oestradiol in hepatitis E virus-infected pregnant women promotes viral replication. J. Viral Hepat. 25, 742\u2013751 (2018).","journal-title":"J. Viral Hepat."},{"key":"361_CR202","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00404-017-4501-y","volume":"296","author":"A Kumar","year":"2017","unstructured":"Kumar, A. et al. Impact of maternal nutrition in hepatitis E infection in pregnancy. Arch. Gynecol. Obstet. 296, 885\u2013895 (2017).","journal-title":"Arch. Gynecol. Obstet."},{"key":"361_CR203","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","volume":"55","author":"DB Rein","year":"2012","unstructured":"Rein, D. B. et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 55, 988\u2013997 (2012).","journal-title":"Hepatology"},{"key":"361_CR204","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.2105\/AJPH.2012.300749","volume":"102","author":"ES Gurley","year":"2012","unstructured":"Gurley, E. S. et al. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection. Am. J. Public Health 102, 2248\u20132254 (2012).","journal-title":"Am. J. Public Health"},{"key":"361_CR205","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/jvh.12730","volume":"24","author":"S Sharma","year":"2017","unstructured":"Sharma, S. et al. Risk factors for vertical transmission of hepatitis E virus infection. J. Viral Hepat. 24, 1067\u20131075 (2017).","journal-title":"J. Viral Hepat."},{"key":"361_CR206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2019.04.017","volume":"270","author":"T Nishiyama","year":"2019","unstructured":"Nishiyama, T. et al. Screening of novel drugs for inhibiting hepatitis E virus replication. J. Virol. Methods 270, 1\u201311 (2019).","journal-title":"J. Virol. Methods"},{"key":"361_CR207","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/tri.12305","volume":"27","author":"VR Bertuzzo","year":"2014","unstructured":"Bertuzzo, V. R. et al. Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus. Transpl. Int. 27, e87\u2013e89 (2014).","journal-title":"Transpl. Int."},{"key":"361_CR208","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/21645515.2015.1008870","volume":"11","author":"SW Li","year":"2015","unstructured":"Li, S. W. et al. The development of a recombinant hepatitis E vaccine HEV 239. Hum. Vaccin. Immunother. 11, 908\u2013914 (2015).","journal-title":"Hum. Vaccin. Immunother."},{"key":"361_CR209","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1080\/21645515.2018.1469591","volume":"14","author":"Y Cao","year":"2018","unstructured":"Cao, Y. et al. Development of new hepatitis E vaccines. Hum. Vaccin. Immunother. 14, 2254\u20132262 (2018).","journal-title":"Hum. Vaccin. Immunother."},{"key":"361_CR210","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033702","volume":"10","author":"K Zaman","year":"2020","unstructured":"Zaman, K. et al. HEV study protocol: design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. BMJ Open 10, e033702 (2020).","journal-title":"BMJ Open"},{"key":"361_CR211","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/21645515.2016.1141844","volume":"12","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y. et al. A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions. Hum. Vaccin. Immunother. 12, 2003\u20132009 (2016).","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-020-00361-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-020-00361-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-020-00361-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:36:26Z","timestamp":1698230186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-020-00361-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":211,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1038\/s41575-020-00361-w","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"21 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.A.T. has received institutional grant support unrelated to this work from Gilead Sciences and Roche\/Genentech. M.T.L. is an adviser or has received research grants from AbbVie, Gilead Sciences, Merck\/MSD and Bayer. G.J. owns equities in Sanofi and has received grants from Gilead. K.W.C. has no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}